Abstract

APP Pharmaceuticals' Abbreviated New Drug Application (ANDA) for injectable polymyxin B (500 000 units/vial) has been approved by the US FDA.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call